- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Studies on uricosuric diuretics. II. 6,7-Dichloro-4-nitro-, 6,7-dichloro-4-sulfamoyl- and 6,7-dichloro-4-acyl-2,3-dihydrobenzofuran-2-carboxylic acids.
-
- HARADA HIROSHI
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- MATSUSHITA YOSHIHIRO
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- YODO MITSUAKI
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- NAKAMURA MASUHISA
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- YONETANI YUKIO
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
Search this article
Description
2, 3-Dihydrobenzofuran-2-carboxylic acids substituted with electronegative nitro, acyl and sulfamoyl groups at the 4-position were synthesized and tested for oral diuretic and saluretic activities in rats and mice. The intraperitoneal uricosuric activity was also tested by a clearance method using oxonate-treated rats. The 4-nitro compounds (11b, 12b, 13b and 14b) showed more potent saluretic activity than the corresponding 5-nitro compounds (7b, 18b, 19b and 20). Although the 5-acyl compounds were reported to show potent saluretic activities, the 4-acyl compounds (41a and b) had much lower activities. On the other hand, the saluretic activities of the 4-sulfamoyl compounds (22a-e) were as potent as those of the 5-sulfamoyl compounds reported previously. Uricosuric activity was found in 14b and 22a.
Journal
-
- Chemical and Pharmaceutical Bulletin
-
Chemical and Pharmaceutical Bulletin 35 (8), 3215-3226, 1987
The Pharmaceutical Society of Japan